Encompass Health (NYSE:EHC) PT Lowered to $65.00

Encompass Health (NYSE:EHCGet Rating) had its price objective dropped by equities researchers at BMO Capital Markets from $83.00 to $65.00 in a research report issued to clients and investors on Thursday, The Fly reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price objective would indicate a potential upside of 22.85% from the company’s current price.

A number of other equities analysts have also recently commented on EHC. Stephens cut their target price on shares of Encompass Health from $78.00 to $74.00 and set an “overweight” rating on the stock in a report on Tuesday, June 21st. Deutsche Bank Aktiengesellschaft cut their target price on shares of Encompass Health from $80.00 to $62.00 in a report on Wednesday. Truist Financial cut their target price on shares of Encompass Health from $85.00 to $75.00 and set a “buy” rating on the stock in a report on Tuesday, June 21st. Raymond James cut their target price on shares of Encompass Health from $85.00 to $70.00 in a report on Friday, June 17th. Finally, Barclays cut their target price on shares of Encompass Health from $80.00 to $63.00 and set an “overweight” rating on the stock in a report on Thursday. One research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $74.60.

Encompass Health Stock Up 0.1 %

EHC stock opened at $52.91 on Thursday. The company has a current ratio of 1.24, a quick ratio of 1.26 and a debt-to-equity ratio of 1.29. Encompass Health has a twelve month low of $44.33 and a twelve month high of $81.45. The company’s 50 day moving average is $54.14 and its two-hundred day moving average is $62.81. The stock has a market cap of $5.28 billion, a P/E ratio of 16.17, a PEG ratio of 2.41 and a beta of 0.91.

Encompass Health (NYSE:EHCGet Rating) last released its quarterly earnings data on Monday, August 1st. The company reported $0.89 earnings per share for the quarter, missing analysts’ consensus estimates of $0.97 by ($0.08). Encompass Health had a return on equity of 16.20% and a net margin of 6.22%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.34 billion. During the same period in the previous year, the business posted $1.17 EPS. The firm’s revenue for the quarter was up 3.3% compared to the same quarter last year. Research analysts expect that Encompass Health will post 3.02 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Encompass Health

Several institutional investors have recently made changes to their positions in EHC. Meeder Asset Management Inc. purchased a new stake in shares of Encompass Health during the 1st quarter worth $33,000. Worth Asset Management LLC purchased a new stake in shares of Encompass Health during the 1st quarter worth $35,000. Covestor Ltd purchased a new stake in shares of Encompass Health during the 4th quarter worth $38,000. Allworth Financial LP boosted its position in shares of Encompass Health by 83.1% in the 1st quarter. Allworth Financial LP now owns 630 shares of the company’s stock worth $45,000 after buying an additional 286 shares in the last quarter. Finally, Rather & Kittrell Inc. purchased a new stake in shares of Encompass Health in the 4th quarter worth about $49,000. 91.70% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Company Profile

(Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading

The Fly logo

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.